Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin: Results From a Randomized Double Blinded Clinical Trial

To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin

To observe the efficacy, effect on glycemic control, impact on BMI and incidence of adverse effects of Dulaglutide and to compare it to Liraglutide in individuals aged thirteen to eighteen who have Type 2 diabetes mellitus and are obese.

Inclusion Criteria:

• Type 2 Diabetes Mellitus
• Obese
• Taking metformin
• Male or female

Exclusion Criteria:

• Non obese
• Not taking metformin
• Taking other injectable diabetic medications